ClinicalTrials.gg
Drug

Gabapentin enacarbil clinical trials

Also written XP13512, GSK1838262, Horizant and HORIZANT 300 mg.

studies test it
31
open now
1
in phase 3
6
first study started
2006

How each study uses gabapentin enacarbil is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the gabapentin enacarbil studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
6 Apr 2011 · HORIZANT · NDA 022399 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

gabapentin enacarbil
18
GEn 1200mg/day
3
GEn 3600mg/day
3
Gabapentin Enacarbil (GEn)
2
XP13512/GSK1838262
2

Brand

Horizant
6
HORIZANT 300 mg
2
HORIZANT 600 mg
2

Development codes

XP13512
10
GSK1838262
8
ASP8825
5

Studies by the year they started

31 studies that test it; most in 2008 (6)

Studies that test gabapentin enacarbil, by start year
YearStudies
20064
20075
20086
20091
20112
20121
20131
20141
20152
20165
20172
20211

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
9
Phase 3
6
Phase 4
9
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 25 · Other 6

XenoPort, Inc. (17) · Astellas Pharma Inc (7) · Arbor Pharmaceuticals, Inc. (1) · The Cleveland Clinic (1) · University of Missouri-Columbia (1) · National Institute on Alcohol Abuse and Alcoholism (NIAAA) (1) · University of Texas at Austin (1) · Theresa Zesiewicz, MD (1)

Often tested with

Tested in the same studies.

Morphine (1) · Gabapentin (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses gabapentin enacarbil is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 31

See all 31 studies that test gabapentin enacarbil →

Codes

What other systems call gabapentin enacarbil · ClinicalTrials.gg INT004712

  • UNII (FDA) 75OCL1SPBQGABAPENTIN ENACARBILConfirmed FDA, Wikidata
  • RxNorm 1101333Confirmed FDA, Wikidata
  • Wikidata Q5515257gabapentin enacarbilConfirmed FDA, Wikidata
  • NCI Thesaurus C79579Gabapentin EnacarbilOne source FDA
  • DrugBank DB08872One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.